Potential Application of Copper Aspirinate in Preventing and Treating Thromboembolic Diseases

The efficacy of copper aspirinate against thrombotic diseases has been tested in animal models. The results show that copper aspirinate, following ig pretreatment for 7 days at 0.012mmol/kg markedly prolonged the bleeding time and inhibited the mortality induced by arachidonic acid (AA) in mice. On...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Weiping, Xiong, Huizhou, Yang, Yikun, Li, Ling, Shen, Zhiqiang, Chen, Zhihe
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365110/
https://www.ncbi.nlm.nih.gov/pubmed/18475833
http://dx.doi.org/10.1155/MBD.1998.123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365110/
https://www.ncbi.nlm.nih.gov/pubmed/18475833
http://dx.doi.org/10.1155/MBD.1998.123

Ejemplares similares